Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement.

ABSTRACT:

Background

While Transcatheter Aortic Valve Replacement (TAVR) is increasingly performed in patients with severe aortic stenosis, the impact of Hematologic Malignancies (HM) on associated outcomes, remains unclear. The authors The authors used a contemporary national database to investigate whether HM is associated with adverse clinical and financial outcomes following elective TAVR.

Materials and methods

The authors The authors identified all adult (≥ 18-years) hospitalizations for elective TAVR in the 2016-2021 Nationwide Readmissions Database. Multivariable models were constructed to evaluate the association of HM with in-hospital mortality, major complications, non-home discharge, Length of Stay (LOS), index hospitalization costs, and 30-/90-day non-elective readmissions

SUBMITTER: Liu Z 

PROVIDER: S-EPMC12344253 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature